Bladder cancer used to be a disease with very few effective treatment options. That was until two new strategies came on the scene: immunotherapies and antibody drug conjugates. These approaches have changed the way doctors treat bladder cancer, and prolonged the lives of many patients. Dr. Tom Powles, head of Barts Cancer Institute, tells Chuck and Alicia about his work on developing these treatments and where he hopes science will take us next.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Charles Ryan MD, Alicia Morgans MD MPH. Innehållet i podden är skapat av Charles Ryan MD, Alicia Morgans MD MPH och inte av, eller tillsammans med, Poddtoppen.